Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 30, 2021

View Archived Issues

Bristol Myers Squibb identifies new Toll-like receptor 7 agonists

Mindset Pharma discloses 5-HT2A receptor agonists

Merck & Co. and The Walter and Eliza Hall Institute of Medical Research divulge new antimalarials

Gasherbrum Bio presents new GLP-1 receptor agonists

LX-9211: development of an AAK1 inhibitor for neuropathic pain

Study may lead to new pulmonary fibrosis treatments

CELMoD CC-99282 for hematological malignancies

TH-1902, a new docetaxel-peptide conjugate with efficacy in SORT1-positive TNBC models

Pan-caspase inhibitor shows in vivo efficacy against MRSA and other bacterial skin infections

Novel quinuclidine modulator of cellular progranulin shows promising ADME-PK properties

Homozygous missense variant in PTPN2 gene tied to early-onset Crohn's disease

Innovent Biologics and Bolt Biotherapeutics collaborate to develop ISAC candidates

Insilico Medicine to use 4B Technologies' AI technology in drug discovery for neurological diseases

Preclinical data support role of idronoxil as anti-inflammatory for early-stage COVID-19